Browsing Tag
NTD Thalassemia
1 post
Agios Pharmaceuticals Inc.’s Stock Soars on Positive Phase 3 Trial Results
Agios Pharmaceuticals Inc.’s stock (AGIO, +2.51%) experienced a significant surge of 19.6% early Wednesday following the announcement of…
